Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Normalized Income (Quarterly)
Normalized Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Normalized Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
Date | Value |
---|---|
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
Normalized Income Definition
Normalized Income is the company's income after removing expenses and revenue that are not recurring. Normalized income gives investors a better idea of the company's income in a "normal" year.